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Tiagabine (Gabitril®) is a selective inhibitor of the
human gamma-aminobutyric acid (GABA) transporter 1
(hGAT-1), a transport protein belonging to the family of
neurotransmitter-sodium-symporters (NSS). It is a mar-
keted drug, used for treatment of epilepsy. However, the
molecular basis of protein-ligand interaction remains
obscure due to the lack of a 3D structure of the target
protein.
In order to identify activity-determining structural fea-
tures of a series of tiagabine analogs taken from literature
[1-3], we chose an approach combining traditional meth-
ods of molecular modeling with exhaustive sampling of
docking poses, and a pairwise comparison of structural
features and their respective bioactivity values.
We determined a common binding mode of tiagabine
analogs, which is in nice agreement with literature [4].
Further, we were able to trace back considerable differ-
ences in inhibitory activities to distinct molecular attri-
butes of the analogs.
Our study revealed the molecular explanation for the
importance of a polar linker region and thus paves the
way for subsequent screening efforts in the search for
novel GAT-1 inhibitors.
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